Kodai Capital Management »

BioCryst Pharmaceuticals shares owned by Kodai Capital Management

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Kodai Capital Management from 13F filings

Historical chart of Kodai Capital Management investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Kodai Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Kodai Capital Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $3.5M 469k 7.50

More positions owned by Kodai Capital Management

At&t (T)
W.W. Grainger (GWW)
Equinix (EQIX)
MKS Instruments (MKSI)
Netflix (NFLX)
Emerson Electric (EMR)
Charter Communications Inc N Cl A (CHTR)
Twilio Cl A (TWLO)
Ambarella SHS (AMBA)
Key (KEY)
Intuit (INTU)
Electronic Arts (EA)
Visa Com Cl A (V)
Oracle Corporation (ORCL)
Allegro Microsystems Ord (ALGM)

View all positions for Kodai Capital Management

Top funds holding BioCryst Pharmaceuticals

Vanguard Group
BlackRock
Deerfield Management Company
State Street Corporation
Kynam Capital Management
UBS Group
Alkeon Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
Hood River Capital Management
Nuveen
Assenagon Asset Management

View all funds holding BioCryst Pharmaceuticals